Ritedose Announces Launch of New Unit Dose Syringe Product: <em>Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL)</em>
COLUMBIA, S.C. (March 25, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL). It is the first of 12 Ritedose products expected to hit the market over the next six months for
“The Ritedose Corporation is honored and proud to have been selected as a subcontractor to ApiJect for the production of single-dose prefilled syringes intended for administering COVID-19 vaccines. This is a direct result of the commitment demonstrated each day by the talented and dedicated people who work here.
COLUMBIA, SC—Keeping homeless families intact is difficult under the best circumstances. The historic pandemic adds to the challenges.
The Ritedose Corporation, a Columbia based pharmaceutical company, takes decisive action in response to the community impact of COVD-19 announcing it has donated about 1,500 bottles of hand sanitizer to Prisma Health and other South Carolina healthcare facilities.